Impower110: Interim OS Analysis of a Phase III Study Of Atezolizumab (ATEZO) vs Platinum-Based Chemotherapy (Chemo) as 1L Treatment (TX) in PD-L1-Selected NSCLC

Author
Enquist, Ida
Kotnatsubara, Kim
Deng, Yu
Kuriki, Hiroshi
Wen, Xiaohui
Jassem, Jacek
Reinmuth, Niels
Spigel, David
De Marinis, Filippo
Giaccone, Giuseppe
Verynenegre, Alain
Barrios, Carlos Henrique
Morise, Masahiro
Felip, Enriqueta
Andric, Zoran
Geater, Sarayut
Ozgueroglur, Mustafa
Mocci, Simonetta
Mccleland, Mark
Herbst, Roy S.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/134353
Collections